menu
    • menu

    Company profile for Foundation for Angelman Syndrome Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Foundation for Angelman Syndrome Therapeutics (or FAST) is an organization of families and professionals dedicated to finding a cure for Angelman Syndrome and related disorders through the funding of an aggressive research agenda, education, and advocacy. The Foundation is committed to assisting individuals living with Angelman Syndrome to realize their full potential and quality of life. We are confident that our goals a...
    The Foundation for Angelman Syndrome Therapeutics (or FAST) is an organization of families and professionals dedicated to finding a cure for Angelman Syndrome and related disorders through the funding of an aggressive research agenda, education, and advocacy. The Foundation is committed to assisting individuals living with Angelman Syndrome to realize their full potential and quality of life. We are confident that our goals are now within reach and together, with your help, we will change lives. Now accepting grant applications for research directed at finding a cure for Angelman Syndrome.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Foundation for Angelman Syndrome TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    PO Box 608 Downers Grove, IL 60515
    Telephone
    Telephone
    (866) 783-0078
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cureangelman.org/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/foundation-for-angelman-syndrome-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cureangelman

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FuturHealth to Distribute Affordable FDA-Approved GLP-1s
    FuturHealth to Distribute Affordable FDA-Approved GLP-1s

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/futurhealth-to-deliver-affordable-fda-approved-glp-1s-nationwide-302517831.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share
    FDA Pathways Offer Faster Track for Oncology Drug Development
    FDA Pathways Offer Faster Track for Oncology Drug Development

    21 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/sponsored/fda-pathways-offer-faster-track-oncology-drug-development

    FIERCE BIOTECH
    21 Jul 2025
    Share Share
    FAST: New Drug Development Accelerator For Angelman Syndrome Therapeutics
    FAST: New Drug Development Accelerator For Angelman Syndrome Therapeutics

    04 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-foundation-for-angelman-syndrome-therapeutics-fast-announces-the-establishment-of-an-associated-drug-development-accelerator-302163387.html

    PR NEWSWIRE
    04 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search